Slides
Page 1
ORYZON ladademstat in AML Preparing for registrational development Two clinical assets in epigenetics Investor presentation Q4 2026 ORY : SM /ORY.MC
Loading workspace
ORYZON ladademstat in AML Preparing for registrational development Two clinical assets in epigenetics Investor presentation Q4 2026 ORY : SM /ORY.MC
Your watchlist and earnings event details are available after you sign in.